Collaboration between Cohen Veterans Bioscience and Siemens Healthineers to Enhance Neuroimaging Library
Cohen Veterans Bioscience and Siemens Healthineers Join Forces
Cohen Veterans Bioscience, a renowned non-profit organization focusing on brain health, has announced a strategic partnership with Siemens Healthineers, a leader in medical technology. Together, they aim to expand the National Normative Neuroimaging Library (NNL) by integrating advanced blood-based biomarker data. This collaboration is poised to revolutionize the field of neurology and psychiatry by enhancing research capabilities and improving diagnostic precision.
What is the National Normative Neuroimaging Library (NNL)?
Established by CVB in collaboration with some of the leading academic institutions, the NNL is one of the largest and most comprehensive repositories of high-quality brain imaging alongside clinical data from nearly 1,900 healthy adults. This unique resource is crucial for researchers who seek to delineate normative brain structure and function as distinct from alterations due to diseases. It aims to significantly improve diagnoses, validate biomarkers, and expedite the development of new therapies targeting neurological and psychiatric disorders.
A Game-Changer for Brain Health Research
One of the standout features of this partnership is Siemens Healthineers' contribution of data related to its high-performance Atellica IM Neurofilament Light Chain assay and other biomarker technologies. These biomarkers are recognized as pivotal indicators of neuronal injury and neurodegeneration. By incorporating these advanced blood-based biomarkers into the existing imaging and clinical data, the NNL will adopt a multimodal approach that promises to set a new standard in brain health research.
Dr. Magali Haas, the Board Chair at CVB, emphasized, "This expansion of the NNL represents a breakthrough resource for the field. By linking blood-based biomarkers with imaging and clinical measures, we expect to advance multimodal modeling, with the aim of improving diagnosis and accelerating the development of new treatments for those living with brain disorders."
Accelerating Research and Improving Outcomes
Dr. Arejas J. Uzgiris, the neurology innovation lead at Siemens Healthineers, highlighted the potential impact of this collaboration. He stated, "We expect this partnership to enable laboratory insights that can translate into clinical benefits. Comprehensive access to advanced diagnostic data will speed up research related to brain disorders and neurodegenerative diseases. This effort can lead to earlier and more accurate diagnoses as well as better prevention strategies, ultimately helping identify patients who can benefit from disease-modifying treatments globally."
About Cohen Veterans Bioscience
Cohen Veterans Bioscience is a non-profit 501(c)(3) organization that is dedicated to promoting brain health by advancing precision diagnostics and personalized therapeutics. The organization collaborates with leading institutions, including the University of Virginia, University of Utah, and Baylor College of Medicine, to further its mission and enhance its research portfolio. To learn more about the NNL and other biomarker initiatives, visit Cohen Veterans Bioscience.
Looking Ahead
As the partnership progresses, the implications for clinical practice and research will undoubtedly serve to advance our understanding of brain health, paving the way for innovative treatment approaches that can profoundly impact the lives of individuals living with brain disorders. This initiative underscores a significant step towards improved health outcomes through collaborative research and the integration of diverse data sets in the field of biomedical science.
Cohen Veterans Bioscience, a renowned non-profit organization focusing on brain health, has announced a strategic partnership with Siemens Healthineers, a leader in medical technology. Together, they aim to expand the National Normative Neuroimaging Library (NNL) by integrating advanced blood-based biomarker data. This collaboration is poised to revolutionize the field of neurology and psychiatry by enhancing research capabilities and improving diagnostic precision.
What is the National Normative Neuroimaging Library (NNL)?
Established by CVB in collaboration with some of the leading academic institutions, the NNL is one of the largest and most comprehensive repositories of high-quality brain imaging alongside clinical data from nearly 1,900 healthy adults. This unique resource is crucial for researchers who seek to delineate normative brain structure and function as distinct from alterations due to diseases. It aims to significantly improve diagnoses, validate biomarkers, and expedite the development of new therapies targeting neurological and psychiatric disorders.
A Game-Changer for Brain Health Research
One of the standout features of this partnership is Siemens Healthineers' contribution of data related to its high-performance Atellica IM Neurofilament Light Chain assay and other biomarker technologies. These biomarkers are recognized as pivotal indicators of neuronal injury and neurodegeneration. By incorporating these advanced blood-based biomarkers into the existing imaging and clinical data, the NNL will adopt a multimodal approach that promises to set a new standard in brain health research.
Dr. Magali Haas, the Board Chair at CVB, emphasized, "This expansion of the NNL represents a breakthrough resource for the field. By linking blood-based biomarkers with imaging and clinical measures, we expect to advance multimodal modeling, with the aim of improving diagnosis and accelerating the development of new treatments for those living with brain disorders."
Accelerating Research and Improving Outcomes
Dr. Arejas J. Uzgiris, the neurology innovation lead at Siemens Healthineers, highlighted the potential impact of this collaboration. He stated, "We expect this partnership to enable laboratory insights that can translate into clinical benefits. Comprehensive access to advanced diagnostic data will speed up research related to brain disorders and neurodegenerative diseases. This effort can lead to earlier and more accurate diagnoses as well as better prevention strategies, ultimately helping identify patients who can benefit from disease-modifying treatments globally."
About Cohen Veterans Bioscience
Cohen Veterans Bioscience is a non-profit 501(c)(3) organization that is dedicated to promoting brain health by advancing precision diagnostics and personalized therapeutics. The organization collaborates with leading institutions, including the University of Virginia, University of Utah, and Baylor College of Medicine, to further its mission and enhance its research portfolio. To learn more about the NNL and other biomarker initiatives, visit Cohen Veterans Bioscience.
Looking Ahead
As the partnership progresses, the implications for clinical practice and research will undoubtedly serve to advance our understanding of brain health, paving the way for innovative treatment approaches that can profoundly impact the lives of individuals living with brain disorders. This initiative underscores a significant step towards improved health outcomes through collaborative research and the integration of diverse data sets in the field of biomedical science.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.